-transparent.png){kind=logo}
Twenty patients with measurable metastatic renal cell carcinoma (RCC) were were treated with interferon alfa-2a (Roferon-A), 36 X 10(6)U intramuscularly 3 times weekly, alone (2 patients) or in combination with vinblastine, 0.10-0.15 mg/kg intravenously every 2 to 3 weeks. Objective responses in the lung, bone, liver, and lymph node metastases were seen in 6 of 18 evaluable patients. Dose reduction of interferon alfa-2a was necessary in 19 of the 20 patients due to intolerable flu-like side effects and fatigue. Bone marrow suppression and increase of gamma-GT represented the most often observed objective toxicity. The preliminary results of this combination treatment in RCC are promising and warrant randomized studies exploring the role of vinblastine. The dose of interferon alfa-2a should be reduced by 50% to avoid excessive toxicity and to maximize patient compliance.
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
April 1992,
Annals of oncology : official journal of the European Society for Medical Oncology,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
February 1989,
American journal of clinical oncology,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
December 1991,
Journal of chemotherapy (Florence, Italy),
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
January 1990,
Acta oncologica (Stockholm, Sweden),
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
April 1998,
The New England journal of medicine,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
July 1987,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
October 1988,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
January 1997,
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
November 1989,
British journal of urology,
S D Fosså, and
S T de Garis, and
M S Heier, and
A Flokkmann, and
H H Lien, and
A Salveson, and
B Moe
November 1987,
Presse medicale (Paris, France : 1983),
